Valley National Advisers’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$130K Sell
5,371
-1,001
-16% -$24.2K 0.02% 280
2025
Q1
$132K Buy
+6,372
New +$132K 0.02% 261
2024
Q2
Sell
-1,089
Closed -$31K 1174
2024
Q1
$31K Sell
1,089
-715
-40% -$20.4K ﹤0.01% 467
2023
Q4
$59K Sell
1,804
-1,377
-43% -$45K 0.01% 379
2023
Q3
$89K Sell
3,181
-1,123
-26% -$31.4K 0.02% 311
2023
Q2
$147K Hold
4,304
0.02% 270
2023
Q1
$130K Sell
4,304
-15
-0.3% -$453 0.02% 272
2022
Q4
$135K Sell
4,319
-4,045
-48% -$126K 0.02% 273
2022
Q3
$271K Sell
8,364
-15,011
-64% -$486K 0.06% 213
2022
Q2
$880K Buy
23,375
+3,113
+15% +$117K 0.19% 100
2022
Q1
$931K Sell
20,262
-14,744
-42% -$677K 0.18% 119
2021
Q4
$2.14M Sell
35,006
-64
-0.2% -$3.92K 0.4% 70
2021
Q3
$2.62M Buy
35,070
+2,482
+8% +$185K 0.47% 44
2021
Q2
$3.01M Buy
32,588
+3,202
+11% +$296K 0.55% 30
2021
Q1
$2.61M Buy
29,386
+2,013
+7% +$179K 0.51% 35
2020
Q4
$2.55M Buy
27,373
+5,333
+24% +$497K 0.54% 33
2020
Q3
$1.4M Buy
22,040
+1,886
+9% +$120K 0.32% 52
2020
Q2
$1.05M Sell
20,154
-1,027
-5% -$53.6K 0.24% 70
2020
Q1
$663K Sell
21,181
-2,821
-12% -$88.3K 0.18% 92
2019
Q4
$805K Buy
24,002
+10,088
+73% +$338K 0.2% 90
2019
Q3
$411K Buy
13,914
+2,362
+20% +$69.8K 0.11% 130
2019
Q2
$398K Buy
11,552
+1,574
+16% +$54.2K 0.11% 127
2019
Q1
$328K Buy
9,978
+9,369
+1,538% +$308K 0.09% 142
2018
Q4
$15K Buy
+609
New +$15K ﹤0.01% 400